Jason Zemansky

Stock Analyst at B of A Securities

(4.88)
# 53
Out of 5,152 analysts
52
Total ratings
77.78%
Success rate
46.83%
Average return

Stocks Rated by Jason Zemansky

Eikon Therapeutics
Mar 2, 2026
Initiates: Buy
Price Target: $34
Current: $14.50
Upside: +134.48%
Inhibikase Therapeutics
Jan 21, 2026
Initiates: Buy
Price Target: $6
Current: $1.87
Upside: +220.86%
Keros Therapeutics
Nov 28, 2025
Maintains: Neutral
Price Target: $18$19
Current: $11.09
Upside: +71.40%
Arcus Biosciences
Nov 28, 2025
Maintains: Neutral
Price Target: $17$26
Current: $21.73
Upside: +19.65%
Rocket Pharmaceuticals
Nov 18, 2025
Maintains: Buy
Price Target: $10$8
Current: $4.40
Upside: +81.82%
Werewolf Therapeutics
Nov 18, 2025
Maintains: Buy
Price Target: $8$7
Current: $0.60
Upside: +1,071.55%
Insmed
Oct 27, 2025
Maintains: Buy
Price Target: $142$187
Current: $142.94
Upside: +30.82%
Cytokinetics
Oct 2, 2025
Maintains: Neutral
Price Target: $52$56
Current: $60.50
Upside: -7.44%
Travere Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $29$31
Current: $26.68
Upside: +16.19%
Kura Oncology
Nov 22, 2024
Maintains: Buy
Price Target: $36$29
Current: $8.65
Upside: +235.26%
Maintains: Buy
Price Target: $30$31
Current: $21.48
Upside: +44.32%
Downgrades: Underperform
Price Target: $2.9$2.5
Current: $2.66
Upside: -6.02%